UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor

Molecular cancer therapeutics, 2017-06, Vol.16 (6), p.1010-1020

2017

Volltextzugriff (PDF)

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

Nature communications, 2019-04, Vol.10 (1), p.1772-1772, Article 1772

2019

Volltextzugriff (PDF)

Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions

Nature communications, 2019-04, Vol.10 (1), p.1856-1856, Article 1856

2019

Volltextzugriff (PDF)

Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression

Clinical cancer research, 2017-09, Vol.23 (17), p.5091-5100

2017

Volltextzugriff (PDF)

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors

Journal of clinical oncology, 2015-10, Vol.33 (30), p.3401-3408

2015

Volltextzugriff (PDF)

Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib

Molecular cancer therapeutics, 2017-08, Vol.16 (8), p.1717-1726

2017

Volltextzugriff (PDF)

Immuno-oncology trends: preclinical models, biomarkers, and clinical development

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003231

2022

Volltextzugriff (PDF)

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib : Rationale for patient selection

Cancer research (Chicago, Ill.), 2007-03, Vol.67 (5), p.2226-2238

2007

Volltextzugriff (PDF)

Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist

Cancer research (Chicago, Ill.), 2007-07, Vol.67 (14), p.6899-6906

2007

Volltextzugriff (PDF)

Heterochromatic Deposition of Centromeric Histone H3-Like Proteins

Proceedings of the National Academy of Sciences - PNAS, 2000-01, Vol.97 (2), p.716-721

2000

Volltextzugriff (PDF)

Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer

Cancer research (Chicago, Ill.), 2009-08, Vol.69 (16), p.6522-6530

2009

Volltextzugriff (PDF)

Conference Scene: Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit

Pharmacogenomics, 2011-04, Vol.12 (4), p.465-470

2011

Volltextzugriff (PDF)

Molecular Pathology in Drug Discovery and Development

Platero, J. Suso

1, 2009

Volltextzugriff (PDF)

Fast-tracking drug development with biomarkers and companion diagnostics

Journal of cancer metastasis and treatment, 2024-01

2024

Volltextzugriff (PDF)

Changes in chromosomal localization of heterochromatin-binding proteins during the cell cycle in Drosophila

The Journal of cell biology, 1998-03, Vol.140 (6), p.1297-1306

1998

Volltextzugriff (PDF)

The Case for a Pre-Cancer Genome Atlas (PCGA)

Cancer prevention research (Philadelphia, Pa.), 2016-02, Vol.9 (2), p.119-124

2016

Volltextzugriff (PDF)

Abstract 5027: Detection of soluble protein biomarkers in NSCLC serum samples by meso scale discovery electrochemiluminescence platform

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.5027-5027

2016

Volltextzugriff (PDF)

Abstract 1018: Multiplex immunofluorescence and image analysis to investigate the role of the immune contexture and fibroblast activation for tumor cell budding in colorectal cancer

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1018-1018

2023

Volltextzugriff (PDF)

Abstract 4326: Co-amplification of FGF receptors and ligands in FGFR inhibitor-sensitive cell lines

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4326-4326

2015

Volltextzugriff (PDF)

Abstract 4325: The role of FGFR fusion genes as novel oncogenic targets

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4325-4325

2015

Volltextzugriff (PDF)

Abstract 3990: FGFR3 mutations as novel oncogenic targets

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.3990-3990

2016

Volltextzugriff (PDF)

Abstract 3174: A real-time qPCR approach to detect fusions between the KIF5B and RET genes in non-small cell lung cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3174-3174

2013

Volltextzugriff (PDF)

Abstract 4666: Profiling mesothelin protein expression by immunohistochemistry and gene expression in adenocarcinoma and squamous cell carcinoma of lung

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4666-4666

2014

Volltextzugriff (PDF)

Abstract 1548: Genomic and molecular profiling of NSCLC formalin-fixed paraffin-embedded tumors

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1548-1548

2014

Volltextzugriff (PDF)

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens

BMC cell biology, 2008-01, Vol.9 (1), p.4, Article 4

2008

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(50)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(71)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor

Comprehensive genomic and immunological characterization of Chinese non-small cell lung cancer patients

Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions

Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression

Phase I Dose-Escalation Study of JNJ-42756493, an Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients With Advanced Solid Tumors

Oncogenic Characterization and Pharmacologic Sensitivity of Activating Fibroblast Growth Factor Receptor (FGFR) Genetic Alterations to the Selective FGFR Inhibitor Erdafitinib

Immuno-oncology trends: preclinical models, biomarkers, and clinical development

Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib : Rationale for patient selection

Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist

Heterochromatic Deposition of Centromeric Histone H3-Like Proteins

Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer

Conference Scene: Diagnostics and personalized medicine: observations from the World Companion Diagnostics Summit

Molecular Pathology in Drug Discovery and Development

Fast-tracking drug development with biomarkers and companion diagnostics

Changes in chromosomal localization of heterochromatin-binding proteins during the cell cycle in Drosophila

The Case for a Pre-Cancer Genome Atlas (PCGA)

Abstract 5027: Detection of soluble protein biomarkers in NSCLC serum samples by meso scale discovery electrochemiluminescence platform

Abstract 1018: Multiplex immunofluorescence and image analysis to investigate the role of the immune contexture and fibroblast activation for tumor cell budding in colorectal cancer

Abstract 4326: Co-amplification of FGF receptors and ligands in FGFR inhibitor-sensitive cell lines

Abstract 4325: The role of FGFR fusion genes as novel oncogenic targets

Abstract 3990: FGFR3 mutations as novel oncogenic targets

Abstract 3174: A real-time qPCR approach to detect fusions between the KIF5B and RET genes in non-small cell lung cancer

Abstract 4666: Profiling mesothelin protein expression by immunohistochemistry and gene expression in adenocarcinoma and squamous cell carcinoma of lung

Abstract 1548: Genomic and molecular profiling of NSCLC formalin-fixed paraffin-embedded tumors

The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens

Suchergebnisse filtern